NEWS AND MEDIA
Recent News
Purdue Pharma L.P. and Geisinger Present Interim Analysis from Wearable Health Technology Clinical Trial at PAINWeek® 2018 Annual Conference
Purdue Pharma L.P. and Geisinger Present Interim Analysis fromWearable Health Technology Clinical Trial at PAINWeek® 2018 Annual ConferenceResults Show Successful Uptake of Technology and Increased Patient-Provider Communication STAMFORD, Conn., and DANVILLE, Pa. –…
Purdue Pharma L.P. to Present Data from Three Research Studies at PAINWeek® 2018 Annual Conference
Purdue Pharma L.P. to Present Data from Three Research Studies atPAINWeek® 2018 Annual ConferenceStudies Underscore Company’s Ongoing Commitment to Working Collaboratively onMeaningful Solutions to Address the Opioid Crisis STAMFORD, Conn., September 6, 2018 – Purdue…
Prescription Drug Safety Curriculum Increased Student Knowledge by 49 Percent in its Inaugural Academic Year
Purdue Expands Established Commitment to Include a Statewide Education Program in Collaboration with EVERFI and Connecticut Prevention Network for the 2018-2019 Academic Year STAMFORD, Conn., August 15, 2018 — Purdue Pharma L.P. today announced that, through its…
Observational Study Finds Errors in Online Opioid Drug Information, Potentially Risking Patient Safety
Results highlight need for healthcare professionals and consumers to consult multiple sources of drug information including Full Prescribing Information or manufacturers’ medical information departments to get accurate product information to help support treatment…
Purdue Pharma Led Collaborative Assessment Identifies Alarming Number of Errors in Commonly Used Online Drug Information Compendia
Study highlights need for healthcare professionals and consumers to utilize more than one resource to help support treatment decisions due to large amount of misinformation Stamford, Conn. – Mar. 1, 2016 – Purdue Pharma L.P., today announced the results from the…
Purdue Pharma L.P. Supports Enhanced PhRMA Code on Interactions with Healthcare Professionals
Stamford, CT – July 15, 2008 – Purdue Pharma L.P. enthusiastically supports the enhanced Code on Interactions with Healthcare Professionals recently published by the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA represents the country’s leading…
Latest Tweet
Common Myths About OxyContin® (oxycodone HCl) extended-release tablets
The terms of oxycodone and OxyContin are not interchangeable. Full Prescribing Information, including Boxed Warning. Medication Guide.
New Media Resources
Given the significant public attention that the opioid addiction crisis has received, we have created this website to give you a better understanding of our company’s history, the opioid landscape, our role in helping to address the crisis, and our involvement in opioid litigations.